Alex Sapir, incoming Fulcrum Therapeutics CEO
May 15, 2023 11:13 AM EDTUpdated 11:24 AM
People
R&D

Still un­der clin­i­cal hold, Ful­crum locks in sea­soned com­mer­cial leader as CEO

Amber Tong

Ful­crum Ther­a­peu­tics has re­cruit­ed a new chief ex­ec­u­tive well versed in the mar­ket­ing world amid man­age­ment up­heaval, a full clin­i­cal hold for its sick­le cell …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Sanofi, Ope­nAI, For­ma­tion Bio de­but pa­tient re­cruit­ing tool, will use in Phase 3 mul­ti­ple scle­ro­sis stud­ies

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

Maze's ALS spin­out Trace Neu­ro­science rais­es $101M for ALS and neu­ro work

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

No­var­tis pays $150M up­front to Schrödinger in new drug deal, ramps up soft­ware use

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times